University of Minnesota
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Minnesota sits in the top decile of US sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count).
University of Minnesota: 966 sponsored US clinical trials, 180 recruiting.
University of Minnesota sponsors 966 registered US clinical trials on ClinicalTrials.gov, 180 of them currently recruiting, and 671 completed. 71 of these trials are in Phase 3-4 (later-stage) and 206 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 14 trials.
Top-decile sponsor footprint
University of Minnesota ranks in the top decile of sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
671 of 731 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
966 total, page 3 of 20
Determining the Effect of Six Weeks of Cannabis Abstinence on Fronto- Striatal fMRI Markers in Adolescents With Cannabis Use Disorder (ABSCAN)
NCT06124846
Microelectrode Recordings From the Vagus Nerve in Awake Humans
NCT06016686
Surgical Site Infections and the Microbiome: Understanding the Pathogenesis of Surgical Site Infections
NCT06300892
Normalizing Cervical Intersegmental Kinematics With Spinal Manipulative Therapy
NCT06312696
Aim 3 Particle Swarm Optimization PIGD
NCT05934747
Udall Project 1 Aim 4
NCT05568199
Food at Home Study
NCT06286514
Modeling Tic Change During Behavior Therapy for Tics
NCT06270251
Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC
NCT06197308
ChronoMet: Metabolic and Inflammatory Effects of Eating Timing and Quantity
NCT06161337
Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder
NCT06467461
Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection
NCT06370884
Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients
NCT06378359
To Investigate Airway Oxygen Concentrations During Rigid Bronchoscopy Procedures Performed With High Frequency Jet Ventilation
NCT05881863
Research Evaluating Vagal Excitation AND Anatomical Links
NCT06143293
Social Determinants of Sleep and Obesity
NCT05698693
Trigeminal Evoked Responses to Improve Rhizotomy
NCT05738096
Feasibility of Transcranial Focused Ultrasound to Measure Brain Tumor
NCT05755399
Project SHINE (Sleep Health INitiative for Equity): Culturally Informing a Sleep Extension Intervention for African American Adults
NCT06226077
Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
NCT06058520
The Teaspoon Study - Telefitting Spinal Cord Stimulation for Pain
NCT05741788
Self-Weighing for Adolescents Seeking Obesity Treatment
NCT04837586
Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy
NCT05493722
Coordinated Reset Deep Brain Stimulation for Essential Tremor
NCT05897775
Listening Effort in Cochlear Implant Users
NCT06516575
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
NCT05758246
Sleep-specific DBS Therapy in Parkinson's Disease
NCT05962489
Assessing THE GAY Male Experience With Anal Cancer Prevention Strategies
NCT05628194
Evaluation of the SCALED (SCaling AcceptabLE cDs)
NCT05628207
Extracellular Vesicles as Potential Biomarkers and Therapeutic Target in Gaucher Disease
NCT05843552
Circuit-Based Deep Brain Stimulation for Parkinson's Disease P1A2&3 Catalyst
NCT05658302
Epidural Stimulation After Neurologic Damage: Long-Term Outcomes
NCT05705453
Cognitive and Affective Processes Online
NCT05736471
Non-Invasive and Non-Contact Intracranial Pressure Waveform Recording Using Dynamic Video Ophthalmoscopy
NCT04046523
Udall Project 2 Aim 2A&C
NCT05656586
Magnetic Resonance Spectroscopy Biomarkers IN Type 3 Gaucher Disease (GD3)
NCT05586243
Maternal Stress, Milk Composition, and Preterm Neurodevelopment
NCT05537454
CIFASD 5 tDCS and Cognitive Training
NCT05456321
Maternal Probiotic Supplementation for Improved Outcomes in Infants of Diabetic Mothers
NCT05467150
Natural History Study for DNA Repair Disorders
NCT05484570
Diabetes in African Youth
NCT05454176
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
NCT05426083
Neuroplasticity in RBD
NCT05471960
Intracranial Stimulation Mapping In Epilepsy
NCT05290610
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
NCT04783857
Transdiagnostic Cognitive Biomarkers
NCT04864080
Community-based Exercise Following Revascularization for PAD
NCT04252950
Trigeminal Neuralgia Electrophysiology
NCT05269472
Neurobiological and Psychological Maintenance Mechanisms Associated With Anticipatory Reward in Bulimia Nervosa
NCT04917068
Tdcs And cogNitive traininG cOmbined for AUD (TANGO)
NCT05062369
What is open in the University of Minnesota pipeline
180 recruiting of 966 indexed (19% open); 671 completed (69%).
Phase mix: 71 late (III/IV) vs 206 early (I/II) (early-phase heavy).
Top condition: Obesity (14 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Minnesota: open-pipeline peers nationwide
Peers matched on 966 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 966 trials (± recruiting share)
- Columbia University · 958 trials · 18% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Alabama at Birmingham · 19% recruiting · 1,160 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Minnesota page
966 registered trials is a research-attention snapshot, not an endorsement of University of Minnesota or any single study.
- 180 of University of Minnesota's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Minnesota studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Minnesota pipeline card: 966 registered trials from official public datasets.Report a data error.